
14/07/2025
Kerendia gains new indication; it showed a 16% reduction for CV death and total heart failure events when compared with placebo. https://www.empr.com/news/kerendia-approved-for-patients-with-heart-failure-and-lvef-%e2%89%a540/
MPR provides daily drug news, medication safety alerts & recalls, and industry-supported drug information & education.
Be the first to know and let us send you an email when MPR - Medical Professionals Reference posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to MPR - Medical Professionals Reference:
Want your business to be the top-listed Media Company?